Literature DB >> 11445446

Simian immunodeficiency virus from mandrill (Mandrillus sphinx) SIVmnd experimentally infects human and nonhuman primate cells.

V Poaty-Mavoungou1, R Onanga, I Bedjabaga, E Mavoungou.   

Abstract

This study set out to characterize the features of experimental infection by simian immunodeficiency virus in mandrill (SIVmnd) (Mandrillus sphinx), cynomolgus macaque (Macaca fascicularis), rhesus macaque (Macaca mulatta), chimpanzee (Pan troglodytes), African green monkey (Cercopithecus pygerythrus), baboon (Papio cynocephalus) and human cells. Purified cells were exposed to a primary isolate of SIVmnd grown in the infected mandrill peripheral blood mononuclear cells, and viral p27 gag antigen was quantitated by antigen capture ELISA. Human cells have been found to be infected by SIVmnd. SIVmnd infection in cynomolgus macaque, rhesus macaque, baboon, mandrill and human cells were more effective than in vervet and chimpanzee cells. In addition, the lymphocytic cell lines SupT1, CEMx174 and Molt4 clone 8 were consistently infected by SIVmnd, whereas U937, a monocytic cell line, was not.

Entities:  

Mesh:

Year:  2001        PMID: 11445446     DOI: 10.1016/s1286-4579(01)01415-0

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  2 in total

1.  Noninvasive detection of new simian immunodeficiency virus lineages in captive sooty mangabeys: ability to amplify virion RNA from fecal samples correlates with viral load in plasma.

Authors:  Binhua Ling; Mario L Santiago; Sreelatha Meleth; Bobby Gormus; Harold M McClure; Cristian Apetrei; Beatrice H Hahn; Preston A Marx
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Human and simian immunodeficiency virus-mediated upregulation of the apoptotic factor TRAIL occurs in antigen-presenting cells from AIDS-susceptible but not from AIDS-resistant species.

Authors:  Nayoung Kim; Alicja Dabrowska; Richard G Jenner; Anna Aldovini
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.